| Financial Year |
March 31 2023 |
| Monetary Funds |
54,651,243.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
146,187,168.89 |
| Advances to Suppliers |
1,501,589,110.87 |
| Other Receivables |
30,929,045.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,728,962.20 |
| Dividend Receivable |
-- |
| Inventories |
286,341,469.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,614,675.29 |
| Total Current Assets |
2,058,832,404.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,438,847.76 |
| Investment Properties |
-- |
| Fixed Assetes |
938,281.70 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
569,708,426.04 |
| R&D expenses |
-- |
| Goodwill |
111,851,447.36 |
| Long-Term Deferred and Prepaid Expenses |
7,055,078.87 |
| Deferred Income Tax Assets |
238,055,397.99 |
| Other Non-Current Assets |
62,573,758.56 |
| Sub-Total of Non-Current Assets |
1,376,669,904.10 |
| Total Assets |
3,435,502,308.66 |
| Short-Term Loans |
60,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
461,102,076.16 |
| Accounts Received In Advance |
61,681,813.35 |
| Employee Compensation Payable |
1,779,722.95 |
| Taxes Payable |
1,106,292.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,222,683,749.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,971,888.13 |
| Other Current Liabilities |
64,457.82 |
| Sub-Total of Current Liabilities |
1,840,162,410.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,035,376.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,221,498.37 |
| Total Liabilities |
1,931,383,908.74 |
| Paid-In Capital(Or Share Stock) |
715,900,255.00 |
| Capital Surplus |
3,175,991,508.93 |
| Surplus Reserve |
82,671,375.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,437,029,114.91 |
| Minority Stockholder's Interest |
-19,816,557.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,523,934,956.98 |
| Owner's Equity（Stockholder's Equity） |
1,504,118,399.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,435,502,308.66 |
